Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 606

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 606
---
 reviewing and approving compensation programs as well as the type and amount of compensation to be paid or awarded to non-employee directors; |

| • |     | reviewing and approving the adoption, amendment and termination of New Semnur’s stock option plans, stock appreciation rights plans, pension and profit sharing plans, incentive plans, stock bonus plans, stock purchase plans, bonus plans, deferred compensation plans, 401(k) plans, supplemental retirement plans and similar programs, if any, and the aggregate cash amounts and numbers of shares to be paid or reserved for issuance thereunder; and administering all such plans, establishing guidelines, interpreting plan documents, selecting participants, approving grants and awards and exercising such other power and authority as may be permitted or required under such plans; |

| • |     | reviewing New Semnur’s incentive compensation arrangements to determine whether such arrangements encourage excessive risk-taking, reviewing and discussing at least annually the relationship between New Semnur’s risk management policies and practices and compensation and evaluating compensation policies and practices that could mitigate any such risk; and |

| • |     | reviewing human capital management strategies, programs and policies, including, but not limited to, those regarding recruitment, retention, career development, diversity, equity and inclusion, pay equity, workplace culture and employee engagement. |

In addition, once New Semnur ceases to be an “emerging growth company,” as defined in the JOBS Act, the responsibilities of the compensation committee will also include:

| • |     | reviewing and discussing with appropriate executive officers of New Semnur compensation-related proposals to be considered at New Semnur’s annual meeting, including the Say on Pay Vote and the frequency of the Say on Pay Vote, and the results of any stockholder advisory votes and, based on such discussions, providing recommendations to the New Semnur Board; and |

| • |     | reviewing and discussing with management New Semnur’s Compensation Discussion and Analysis, and recommending to the New Semnur Board that the Compensation Discussion and Analysis be approved for inclusion in New Semnur’s annual reports on Form 10-K, registration statements, New Semnur’s annual meeting proxy statements and information statements. |

Under its charter, the compensation committee may form, and delegate authority to, subcommittees as appropriate. The compensation committee will review, discuss and assess its own performance and composition at least annually. The compensation committee will also periodically review and assess the adequacy of its charter, including its role and responsibilities as outlined in its charter, and recommend any proposed